title: Terpestacin, a new syncytium formation inhibitor from Arthrinium sp.
abstract: Terpestacin, a new antibiotic which inhibits syncytium formation, was isolated from Arthrinium sp. FA1744 (ATCC 74132). The structure of terpestacin was elucidated as a bicyclic sesterterpene on the basis of spectroscopic data and chemical derivatization.
authors: Bristol-Myers Squibb Research Institute, Tokyo, Japan.
authors: M
authors: M
authors: Oka
authors: S
authors: S
authors: Iimura
authors: O
authors: O
authors: Tenmyo
authors: Y
authors: Y
authors: Sawada
authors: M
authors: M
authors: Sugawara
authors: N
authors: N
authors: Ohkusa
authors: H
authors: H
authors: Yamamoto
authors: K
authors: K
authors: Kawano
authors: S L
authors: SL
authors: Hu
authors: Y
authors: Y
authors: Fukagawa
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology; D001643:Bridged Bicyclo Compounds / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D002460:Cell Line; D005285:Fermentation; D015726:Giant Cells / Q000187:drug effects*; D009682:Magnetic Resonance Spectroscopy; D008826:Microbial Sensitivity Tests; D003904:Mitosporic Fungi / Q000737:chemistry*
chemical_list: D000900:Anti-Bacterial Agents; D001643:Bridged Bicyclo Compounds; C080890:terpestacin